Greg Hostetler Email & Phone Number

Philadelphia, Pa, Us

United States

Wilmington, De

Designed and synthesized monomers and polymers for high refractive index applications. Made significant contributions to produce a photopatternable polymer without the use of inorganic additives, leading to co-authorship of a recently filed provisional patent (US20240152047). Synthesized and purified monomers for single mode optical waveguides which resulted in a polymer with very low optical losses.Made a significant contribution as a collaborator by suggesting and synthesizing a monomer to incorporate into an existing polymer framework to produce films with extremely low b* for colorless and flexible cover lenses for OLED displays, leading to co-authorship of a recently filed provisional patent (US20240052104).Performed research to develop the next generation materials for RDL in FO-WLP. Developed one of the project’s lead polyimide candidates and was instrumental in developing a second lead candidate.Involved in the identification and synthesis of novel monomers and poly(amic acid)s to develop colorless polyimide films for electronic applications.

Wilmington, Delaware

Involved in the identification and synthesis of novel monomers and poly(amic acid)s to develop polyimide films for electronic applications.Recipient of the Electronics & Imaging Technologist Excellence Award (June 2018)Designed and synthesized novel compounds supporting the development of organic light-emitting diodes (OLEDs) to optimize the next-generation of display technology, focusing on the synthesis of novel green hosts and blue emitters.

New Castle, De

Worked as a full-time synthetic organic chemist for a pharmaceutical company in a CRO context, providing advanced intermediates and final targets to assist them in their drug discovery efforts regarding a 2nd-generation cancer therapy. Primarily conducted reactions between 5g and 200g scales. Generated novel synthetic methodology for the client and communicated synthetic improvements and project status via weekly teleconferences.

West Chester, Pa

Cognition-enhancing research involving the discovery of H3 antagonists/inverse agonists, and 5-HT6 antagonists, the latter target as a therapeutic agent for schizophrenia. Our most promising candidate, Irdabisant, proceeded into Phase II clinical trials. Involved in Alzheimer's research, designing and synthesizing Tau kinase inhibitors. Independently developed a chemoselective palladium-catalyzed cross-coupling reaction to selectively produce the Buchwald-Hartwig product vs. the Heck product. Designed and synthesized dual GSK-3Beta/CDK5 inhibitors to mitigate the phosphorylation of Tau.Involved in the design and synthesis of small molecule ALK inhibitors for non-small lung cancer.

West Chester, Pa

Cognition-enhancing research involved the design and synthesis of modafinil analogs (second-generation Modafinil).

Wilmington, De

Synthesized tetrameric peptidomimetics as ANP Clearance Receptor antagonists for the treatment of pulmonary hypertension.Synthesized 5-HT1B receptor agonists for depression.Conducted research to produce quinolines as N-Type Calcium channel antagonists for neuropathic pain.Solid-phase synthesis of GsAF-II peptides (9-19 amino acids in length) for neuropathic pain.

Masters, Organic Chemistry

Thesis: Synthetic Studies Towards a Glaucarubolone Analog, Published March 1997. Organic Chemistry Lab Instructor - 6 semesters

B.A. Chemistry

GPA: 3.78